OLE Study to Evaluate Safety / Efficacy of ZD4522

• Status: Completed
• Trial end date: 2005-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the long term safety of Crestor.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Rosuvastatin Calcium

Criteria

Inclusion Criteria:

• Completion of previous Crestor study as listed in the protocol.

Exclusion Criteria:

• Pregnant or breast feeding women, or not using appropriate contraception.

• Abnormal lab values as listed in the protocol.